Lynch Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Hold
10,100
0.41% 39
2025
Q4
$1.06M Buy
10,100
+1,100
+12% +$103K 0.33% 39
2025
Q3
$755K Hold
9,000
0.24% 41
2025
Q2
$712K Buy
9,000
+200
+2% +$15.9K 0.25% 41
2025
Q1
$790K Buy
8,800
+800
+10% +$74.7K 0.35% 40
2024
Q4
$796K Buy
8,000
+1,200
+18% +$124K 0.32% 40
2024
Q3
$772K Buy
6,800
+1,150
+20% +$137K 0.32% 40
2024
Q2
$699K Hold
5,650
0.3% 40
2024
Q1
$746K Hold
5,650
0.35% 41
2023
Q4
$616K Hold
5,650
0.35% 41
2023
Q3
$582K Sell
5,650
-1,000
-15% -$108K 0.38% 40
2023
Q2
$767K Hold
6,650
0.49% 38
2023
Q1
$707K Sell
6,650
-500
-7% -$54K 0.51% 42
2022
Q4
$793K Hold
7,150
0.68% 37
2022
Q3
$615K Hold
7,150
0.55% 39
2022
Q2
$653K Hold
7,150
0.53% 38
2022
Q1
$586K Hold
7,150
0.42% 40
2021
Q4
$549K Buy
+7,150
New +$569K 0.38% 37

Other funds holding MRK

Lynch Asset Management's MRK Position: Q1 2026 in Review

Lynch Asset Management held its Merck (MRK) position steady in Q1 2026 at 10,100 shares worth $1.21M. The position accounts for 0.41% of the portfolio, ranked #39.

Lynch Asset Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Lynch Asset Management held 10,100 shares of Merck worth $1.21M as of Q1 2026.
  • Lynch Asset Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.41% of Lynch Asset Management's portfolio in Q1 2026, its #39 holding.
  • Lynch Asset Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Lynch Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.